Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Henry Schein    HSIC

HENRY SCHEIN (HSIC)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/18/2018 09/19/2018 09/20/2018 09/21/2018 09/24/2018 Date
84.32(c) 84.48(c) 85.88(c) 85.67(c) 83.67 Last
1 043 481 725 227 959 091 1 614 191 1 260 723 Volume
-0.08% +0.19% +1.66% -0.24% -2.33% Change
More quotes
Financials (USD)
Sales 2018 13 416 M
EBIT 2018 898 M
Net income 2018 608 M
Debt 2018 1 672 M
Yield 2018 -
Sales 2019 14 058 M
EBIT 2019 961 M
Net income 2019 680 M
Debt 2019 1 228 M
Yield 2019 -
P/E ratio 2018 21,87
P/E ratio 2019 19,46
EV / Sales2018 1,10x
EV / Sales2019 1,02x
Capitalization 13 117 M
More Financials
Company
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners.It operates through the Healthcare Distribution, and Technology and Value-Added Services segments.The Healthcare Distribution segment includes consumable... 
More about the company
Surperformance© ratings of Henry Schein
Trading Rating : Investor Rating :
More Ratings
Latest news on HENRY SCHEIN
09/20HENRY SCHEIN : Supports Cancer Awareness And Research Through Its 'Practice Pink..
AQ
09/13HENRY SCHEIN, INC. : Builds More Than 17,000 Hygiene Kits For People In Need In ..
PR
09/12HENRY SCHEIN : Supports Cancer Awareness And Research Through Its 'Practice Pink..
PU
09/10HENRY SCHEIN : Disaster Relief Hotline Is Open To Support Customers Affected By ..
PR
09/10HENRY SCHEIN : Opens Application Window For Fourth Annual Henry Schein Cares Med..
PR
09/07HENRY SCHEIN : Helps More Than 5,000 Students Around The World Return To The Cla..
PR
09/05HENRY SCHEIN : One Launches Dentrix® G7 Featuring New Integration with Imaging S..
PU
08/31HENRY SCHEIN : Benco Dental reaches settlement in litigation
AQ
08/30HENRY SCHEIN INC : Results of Operations and Financial Condition, Regulation FD ..
AQ
08/30HENRY SCHEIN : Anticipates Settling Proposed Class-Action Litigation
PR
More news
Sector news : Medical Equipment Wholesale
09/21Disruption to medical business takes toll on Smiths Group
RE
09/21MAZOR ROBOTICS : Medtronic to acquire Mazor in $1.64 billion deal
RE
09/21MEDTRONIC : to Acquire Mazor Robotics for $1.64 Billion
DJ
09/13Smiths and ICU Medical healthcare merger talks collapse
RE
09/11STRYKER : to Buy Invuity for About $190 Million
DJ
More sector news : Medical Equipment Wholesale
MarketScreener Strategies on HENRY SCHEIN 
HENRY SCHEIN, INC. - 2017
Towards the breakout of a major resistance level
BUY
HENRY SCHEIN, INC. - 2017
No turn-around in sight
BUY
More Strategies
Latest Tweets
03:38pCautious analyst note on Henry Schein; shares down more than 1% early  
05:01aPeter McCarthy, emeritus chairman and principal consultant at Consultants, ..
2
09/20Henry Schein $HSIC Sets New 1-Year High at $85.80  
09/16Henry Schein, Inc. $HSIC Short Interest Down 8.4% in August  
09/14$HSIC UNUSUAL BULL SWEEPERS DETECTED 
More tweets
Qtime:80
News from SeekingAlpha
09:38aCautious analyst note on Henry Schein; shares down more than 1% early 
09/04Tracking Al Gore's Generation Investment Management Portfolio - Q2 2018 Updat.. 
08/30Patterson Companies down 18% premarket on soft EPS guidance 
08/23Don't Underestimate The Consumer - Cramer's Mad Money (8/22/18) 
08/07Henry Schein, Inc. 2018 Q2 - Results - Earnings Call Slides 
Chart HENRY SCHEIN
Duration : Period :
Henry Schein Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HENRY SCHEIN
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 82,6 $
Spread / Average Target -3,6%
EPS Revisions
Managers
NameTitle
Stanley M. Bergman Chairman & Chief Executive Officer
James P. Breslawski Vice Chairman & President
Steven Paladino Chief Financial Officer, Director & Executive VP
Christopher Pendergast Chief Technology Officer & Senior Vice President
Philip A. Laskaway Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
HENRY SCHEIN22.60%13 117
COLOPLAST A/S31.96%20 309
AMPLIFON SPA51.56%5 174
CANTEL MEDICAL CORP.-5.41%4 058
MERIT MEDICAL SYSTEMS, INC.42.13%3 361
PATTERSON COMPANIES-28.95%2 440